does the va cover glp-1 drugs Study: Ozempic, Other May Fight Addiction Across Every Major Substance Pentagon Drops Coverage of GLP-1

Pharmacotherapy of obesity: an update on the available medications and drugs under investigation

Mounjaro Tirzepatide Injection, Solution

With consistent use, the Ultimate GLP-1 helps reduce visceral fat and stomach circumference when paired with a healthy diet and exercise, curbs cravings, appetite, hunger, and snacking, and enhances lean mass

US GLP-1 Receptor Agonist Market Analysis The US GLP-1 receptor agonist market was valued at USD 30.15 billion in 2025, driven by increasing prescription volumes for diabetes and chronic weight management, broad availability of innovative therapies, and strong investment in obesity care

In February 2024, we announced that the Phase 2 VENTURE trial successfully achieved its primary endpoint and all secondary endpoints, with patients receiving VK2735 demonstrating statistically significant reductions in body weight compared with placebo